Industry Education

The Society of Critical Care Medicine’s (SCCM) 48th Critical Care Congress will be packed with essential clinical information to keep you informed on the latest groundbreaking research and developments in critical care. Each year, industry partners invest significant resources in research and development, placing them at the cutting edge of clinical practice.​​​​​
Industry partners invest significant resources in research and development, and stand at the cutting edge of clinical practice. These programs, developed and sponsored by industry partners, will provide insight into the latest controversial developments affecting ICUs. Industry Insights Sessions take place in a relaxed setting off site, and attendance is free.

Sunday, February 17, 2019
6:00 p.m. - 7:30 p.m.

Bacteremia in ICU Patients: Updates on Antibiotic Optimization and Patient Management

Organized by: Accelerate Diagnostics
Presenters: Anand Kumar and Katherine Lusardi
Location: Omni San Diego Hotel, Grand Ballroom Salons AB

Dr. Anand Kumar will review recent published literature on the infection management of hospitalized patients with bacteremia, sepsis and septic shock on patient outcomes, discuss the factors that may lead to progression from bacteremia to sepsis to septic shock, and discuss the role of antimicrobial stewardship and antibiotic optimization in ICU patients with sepsis and septic shock. Katherine Lusardi, PharmD will describe the role of appropriate antibiotic de-escalation in ICU patients, review the impact of implementation of a fast phenotypic antibiotic susceptibility diagnostic on management of patients with bacteremia, and provide examples of antibiotic optimization in patients with sepsis.

Monday, February 18, 2019
6:00 p.m. - 7:30 p.m.

How Rapid Diagnostic Testing Can Improve Outcomes in Critically Ill Patients

Organized by: BioFire Diagnostics
Presenters: Tufik Assad and Trevor Van Schooneveld
Location: Omni San Diego Hotel, Grand Ballroom Salons AB

The limits of traditional culture techniques can create challenges in the diagnosis and management of critically ill ICU patients. The syndromic approach to rapid molecular diagnostics can lead to faster, more accurate, and more comprehensive results. Join us as presenters discuss their experiences implementing this solution for patients with pulmonary and systemic infections.
Visit the Exhibit Hall to gain new ideas and a heightened level of awareness on clinical topics and new technologies through in-booth learning opportunities. In-booth education will take place during regular Exhibit Hall hours.

Exhibit Dates
Sunday, February 17, 2019         9:30 a.m. - 3:45 p.m.            
Monday, February 18, 2019        8:30 a.m. - 3:30 p.m.          
Tuesday, February 19, 2019       8:30 a.m. - 1:30 p.m.   

Booth #924
3D Systems Simbionix

Simbionix training simulators help medical professionals practice and master procedures. At our booth, our VR training  simulators will be available for critical care trainees and practitioners: The U/S Mentor, an ultrasound simulator that features Bedside Echo, eFAST, TEE and Lung ultrasound, and the BRONCH Mentor with an extensive bronchoscopy curriculum.

Booth #1043
Agency for Healthcare Research and Quality

Stop by the Agency for Healthcare Research and Quality booth #1043 on Monday, February 18, from 8:45 a.m. to 9:45 a.m. where program official Melissa A. Miller, MD, MS, of the Agency for Healthcare Research and Quality’s Healthcare-Associated Infections Division will be on hand to discuss funding opportunities for research on healthcare-associated infections and combating antibiotic resistance.

Booth #842
Applied Medical Technology, Inc

Visit Booth #842 for a demonstration and opportunity to practice placing the AMT Bridle™ Nasal Tube Retaining System, proven to optimize nutritional outcomes and reduce pullout costs. AMT Bridle™ is cleared for pediatrics and adults and is available in 5-18FR for use with ALL nasogastric and nasojejunal feeding tube brands.

Booth #1039
Auburn University Physicians Executive MBA

Visitors to the Auburn University Physicians Executive MBA booth will be able to speak with Joe Collazo, assistant director and faculty member in our program. Dr. Collazo teaches organizational behavior, leadership, and ethics in the Harbert College of Business.

Booth #543

Please visit the Ceribell Booth (#543) to learn more about our Rapid Response EEG system. It can be set up by any healthcare provider within minutes and offers immediate triage of seizures. We will perform live demos where you can record, view, and listen to your own brainwaves.

Booth #1119
CoapTech, LLC

CoapTech visitors will simulate bedside gastrostomy tube placement using ultrasound guidance—perfect for intensivists, point-of-care ultrasound specialists, or anyone looking to expand her/his repertoire. Explore the PUMA-G System, a novel gastrostomy tube placement system for non-surgical providers, employing readily available medical devices such as ultrasound, feeding tubes, guidewires, and dilators.

Booth #926
Daxor Corporation

New data will be presented on a 20-minute rapid blood test that gives an accurate quantification of total blood volume, plasma volume, and red blood cell volume. Meet the principle investigator at the Daxor Booth (#926) to learn more how this test informs better volume management and has been shown to reduce ICU mortality by 66% and length of stay.

Booth #905
Edwards Lifesciences

Optimizing Perfusion through Hemodynamic Monitoring Managing optimal perfusion in acutely ill patients can prove challenging if appropriate monitoring is not in place. Charles Hunley, MD, will review advanced physiologic principles, how to assess right and left heart function, and explain the application of advanced hemodynamic monitoring through case studies.

Booth #524

Explore virtually every piece of patient data you encounter in an ICU on one customizable screen at booth #524. A touchscreen, desktop, and iPad will be waiting for you with real-life use cases highlighting deteriorating trends. See how Etiometry’s FDA-cleared analytics can transform your data into actionable information.

Booth #1319
Philips Healthcare

Live demonstrations and education on Philips Affiniti and Lumify point-of-care and portable ultrasound, Philips Intellispace eCareManager and Console solution softwares, Philips MX800 monitor and Philips Alar wearable nasal sensor.

Booth #1105

Learning objectives:
  • Perform systematic ultrasound assessment of central and peripheral catheter insertion
  • Identify and review avoidable anatomical surrounding structures
  • Review use of sliding lung assessment for pneumothorax
Sunday, February 17, 2019
10:00 a.m., 11:00 a.m., 2:00 p.m., 3:00 p.m.

Monday, February 18, 2019
10:00 a.m., 11:00 a.m., 2:00 p.m., 3:00 p.m.

Tuesday, February 19, 2019
10:00 a.m., 11:00 a.m.

Booth #1011
Thermo Fisher Scientific

Meet the expert: Gabriel Wardi, MD, assistant professor at the University of California San Diego, is board-certified in critical care medicine and emergency medicine and is clinically active in both fields. He will be ready to answer to your questions about procalcitonin in the Thermo Fisher booth on Sunday, February 17 between 2:00 p.m. and 3:00 p.m.

Booth #1112
Vapotherm, Inc.

Both too much and too little oxygen have important clinical consequences. Vapotherm is evaluating a module that may help clinicians keep patients in a target Spo2 range. Please stop by booth #1112 to see the module and share your thoughts on the approach and recent publication.

Booth #912
Virtual Pediatric Systems, LLC

Virtual Pediatric Systems will have one-on-one demonstrations of comparative data from multiple pediatric ICUs across the country for quality improvement.
Attend exhibitor-sponsored industry education workshops during session breaks. Located in the Exhibit Hall, these workshops will provide additional learning opportunities and insight on late-breaking technology or clinical techniques. Presentations will be held in Theaters 1 and 2 in Exhibit Hall GH.

Sunday, February 17, 2019
9:30 a.m. - 10:30 a.m.

Theater 1
Mask-Free NIV

Sponsored by Vapotherm, Inc.
Presenter: Michael McQueen

HVNI is a form of noninvasive ventilation for spontaneously breathing patients, with a unique FDA category classification. The presentation will cover the mechanisms of action and data from a recent randomized clinical trial, showing that HVNI is a viable alternative to NIPPV as a tool for treating the signs and symptoms of undifferentiated respiratory distress.

Theater 2
Urgent Warfarin Reversal for Fast and Sustained Action: A Case-Based Presentation

Sponsored by CSL Behring
Presenter: Aryeh Shander

This case-based educational session will explore clinical situations in which rapid reversal of warfarin is required in patients experiencing acute major bleeding as well as in those in need of urgent surgery/invasive procedures.

12:45 p.m. - 1:45 p.m.

Theater 1
Multimodal Prognostication After Cardiac Arrest: Is the Neurological Pupil Index (NPi) the Answer?

Sponsored by NeurOptics
Presenters: Mauro Oddo and Giuseppe Citerio

Prognostication of coma after cardiac arrest is challenging and requires a multimodal approach. Join us as we discuss the results of a recent international, multicenter, double-blinded study that demonstrated the value of quantitative pupillometry, using the Neurological Pupil index (NPi), in predicting neurologic prognosis after cardiac arrest. Pupillometry appears to be a widely accessible and easy-to-use device with the potential to provide great accuracy and precise and timely answers to ICU clinicians caring for comatose cardiac arrest patients.

Theater 2
Procalcitonin in 2019: New Data and Applications for the Best Patient Value

Sponsored by Thermo Fisher
Presenter: Gabriel Wardi

Learning Objectives:
  • Review the history, biokinetics, and physiology of procalcitonin in critically ill patients
  • Discuss the rationale and evidence for procalcitonin use in antibiotic stewardship in the ICU
  • Recognize the role of procalcitonin in sepsis bundles and how to effectively implement its use in the ICU
2:45 p.m. - 3:45 p.m.

Theater 1
Diagnosing Atypical Hemolytic Uremic Syndrome: A Patient Case Journey
Sponsored by Alexion Pharmaceuticals
Presenter: Ramy M. Hanna

  • Follow along the patient journey as atypical hemolytic uremic syndrome (aHUS) is diagnosed
  • Review the clinical decisions, supporting information, and clinical data that arise during this journey

Monday, February 18, 2019

8:45 a.m. - 9:45 a.m.

Theater 1
Clinical Experience With Novel Rapid Response EEG System

Sponsored by Ceribell
Presenter: Moussa Yazbeck

This workshop will explore various clinical unmet needs in seizure detection and how the Ceribell Rapid Response EEG System has improved patient care via learnings from real-world usage at multiple hospitals. 

Theater 2
GIAPREZA (Angiotensin II): A Novel Treatment Option for Septic or Other Distributive Shock

Sponsored by LaJolla Pharmaceutical Company
Presenter: Bruce Friedman

This case-based educational session will explore clinical situations in which administering GIAPREZA is used to increase blood pressure in adult patients with distributive or septic shock .

12:15 p.m. - 1:15 p.m.

Theater 1
Reversal of Novel Oral Anticoagulants in Patients Experiencing Life-Threatening Bleeds: Review of Clinical Evidence and Practical Recommendations for Patient Management

Sponsored by Portola Pharmaceuticals
Presenter: Fariborz Rezai

Theater 2
Understanding Pulmonary Embolism Risk Stratification and Reduced Thrombolytic Dose with EKOS Therapy

Sponsored by BTG Vascular
Presenter: Victor F. Tapson

Treat bilateral pulmonary embolism with as little as 8 mg tPA total and in as little as 2 hours:
  • Identify which patients will benefit the most from this new lowerdose, shorter-duration therapy
  • Review the compendium of data supporting EKOS Therapy
  • Learn how pulmonary embolism patients’ right ventricular dysfunction can be effectively treated in as little as 2 hours
2:15 p.m. - 3:15 p.m. 

Theater 1
Earlier Effective Antibiotic Therapy Through Culture- Independent Diagnostics
Sponsored by T2 Biosystems
Presenters: Neil Clancy and Sandy J. Estrada

This workshop will explore the need for early detection and identification of clinically important organisms, including the most prevalent ESKAPE pathogens, to provide earlier targeted therapy for the most critically compromised patients.

Join us as we discuss integrating the FDA-cleared T2Bacteria and T2Candida Panels in clinical practice and how it can impact patient management. Learn how early detection of the most serious bacterial and fungal pathogens in 3 to 5 hours direct from whole blood—and without waiting for blood culture—can improve on empiric therapy protocols and improve patient outcomes.